HemaSphere
(Aug 2023)
P775: LONG-TERM EFFICACY AND SAFETY OF POZELIMAB MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
- Jun-Ho Jang,
- Raymond Wong,
- Jonathan Weyne,
- Umesh Chaudhari,
- Jutta Miller,
- Quang P. Nguyen,
- Morag Griffin
Affiliations
- Jun-Ho Jang
- 1 Samsung Medical Center, Seoul, Korea, Rep. of South
- Raymond Wong
- 2 Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
- Jonathan Weyne
- 3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States
- Umesh Chaudhari
- 3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States
- Jutta Miller
- 3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States
- Quang P. Nguyen
- 3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States
- Morag Griffin
- 4 St James’s University Hospital, Leeds, United Kingdom
- DOI
-
https://doi.org/10.1097/01.HS9.0000970004.43570.16
- Journal volume & issue
-
Vol. 7
p.
e4357016
WeChat QR code